ArticleAbdominal radiology (New York)2025
Dual-energy CT for predicting serosal invasion in gastric cancer and subtype analysis.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Research progress on the application of dual energy CT in gastric diseases.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo predict the serosal invasion of gastric cancer (GC) using dual-energy CT (DECT)-based parameters and analyze the diagnostic performance according to different subtypes.
methodsThe patients were divided into the T1-3 group and T4a group. The irregular region of interest (ROI) was manually delineated on the largest cross-section of the lesion. The ROI area, iodine concentration (IC), normalized iodine concentration (nIC), fat fraction, CT value mean, and standard deviation were measured in the late arterial (LAP) and venous phase (VP). The Mann-Whitney U test was used to assess differences between different T-stage groups and histopathological subtypes of GC. A model was established based on DECT parameters, and the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic performance.
resultsPreliminary analysis showed that there were significant differences in ROI area, IC, nIC and CT value mean in VP and ROI area in LAP between T1-3 and T4a GC (all p < 0.05). The AUC of the comprehensive model composed of ROI and nIC in VP was 0.805. For different subtypes, multiple DECT parameters of poorly cohesive carcinoma (PCC) showed significant differences.
conclusionROI area in LAP and VP, IC, nIC, and CT value mean in VP have significant differences in distinguishing between T1-3 and T4a GC. Iodine-related parameters in VP differed significantly between T1-3 and T4a in PCCs, rather than TACs. Considering the heterogeneity of different WHO subtypes, DECT iodine-related parameters in VP are more predictive of the serosal invasion status of GC compared to LAP.
Indexed as
Identifiers
39690282What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.